These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4004625)

  • 21. Vascular endothelial growth factor and interleukin-6 are correlated with serous retinal detachment in central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T
    Curr Eye Res; 2012 Jan; 37(1):62-7. PubMed ID: 21978265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous protein concentration in rhegmatogenous retinal detachment.
    Oshika T
    Jpn J Ophthalmol; 1990; 34(1):63-71. PubMed ID: 2362376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
    Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Statistical study of aqueous flare in rhegmatogenous retinal detachment].
    Watanabe K; Ideta H; Nakatake J; Shinagawa K; Demizu S; Takenaka C; Miura M
    Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):653-7. PubMed ID: 8067298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concentration of vascular endothelial growth factor within the subretinal space and vitreous fluid in rhegmatogenous retinal detachment].
    Moromizato Y; Hayashi H; Kato H; Ozaki H; Oshima K
    Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):498-502. PubMed ID: 9209137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental retinal detachment. XI. Furosemide-inhibitable fluid absorption across retinal pigment epithelium in vivo.
    Tsuboi S; Pederson JE
    Arch Ophthalmol; 1986 Apr; 104(4):602-3. PubMed ID: 3954667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of combined traction-rhegmatogenous retinal detachment in the morning glory syndrome.
    Harris MJ; de Bustros S; Michels RG; Joondeph HC
    Retina; 1984; 4(4):249-52. PubMed ID: 6543402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitreous and subretinal fluid concentrations of orally administered dabigatran in patients with rhegmatogenous retinal detachment.
    Mulder VC; Kluft C; van Meurs JC
    Acta Ophthalmol; 2016 Nov; 94(7):663-667. PubMed ID: 27496339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoreactive opsin content in subretinal fluid from patients with rhegmatogenous retinal detachments.
    Hara S; Ishiguro S; Hayasaka S; Mizuno K
    Arch Ophthalmol; 1987 Feb; 105(2):260-3. PubMed ID: 2949728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the biological antioxidant potential in the vitreous fluid from patients with rhegmatogenous retinal detachment.
    Maeno A; Suzuki Y; Adachi K; Takahashi S; Yokoi Y; Nakazawa M
    Acta Ophthalmol; 2016 Sep; 94(6):e515-6. PubMed ID: 27008980
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenesis of retinal detachment associated with morning glory disc.
    Bartz-Schmidt KU; Heimann K
    Int Ophthalmol; 1995; 19(1):35-8. PubMed ID: 8537194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental retinal detachment. I. Effect of subretinal fluid composition on reabsorption rate and intraocular pressure.
    Pederson JE; MacLellan HM
    Arch Ophthalmol; 1982 Jul; 100(7):1150-4. PubMed ID: 7092659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental retinal detachment. VIII. Retinochoroidal horseradish peroxidase diffusion across the blood-retinal barrier.
    Toris CB; Pederson JE
    Arch Ophthalmol; 1985 Feb; 103(2):266-9. PubMed ID: 3977697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Level of protein and protein fractions in the subretinal fluid in retinal detachment].
    Akhmeteli LM
    Vestn Oftalmol; 1968; 81(3):61-7. PubMed ID: 5742536
    [No Abstract]   [Full Text] [Related]  

  • 35. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy.
    La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F
    Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal detachment in morning glory syndrome with large hole in the excavated disc.
    Jo YJ; Iwase T; Oveson BC; Tanaka N
    Eur J Ophthalmol; 2011; 21(6):841-4. PubMed ID: 21607925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of soluble syndecan-1 in the subretinal fluid and the vitreous of eyes with rhegmatogenous retinal detachment.
    Wang JB; Tian CW; Guo CM; Du HJ; Liu HL; Zhang YJ; Hui YN
    Curr Eye Res; 2008 Jan; 33(1):101-7. PubMed ID: 18214747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
    Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.